HIV-M. leprae interaction: Can HAART modify the course of leprosy?

Public Health Reports

Volumn 123, Issue 2, 2008, Pages 206-212

  Sarno, Euzenir Nunes ^a   Illarramendi, Ximena ^a   Costa Nery, José A ^a   Sales, Anna M ^a   Gutierrez Galhardo, Maria C ^b   Fernandes Penna, Maria L ^c   Sampaio, Elizabeth Pereira ^a   Kaplan, Gilla ^d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEPROSY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS LOAD; ADULT; CASE CONTROL STUDY; COMORBIDITY; DISEASE PREDISPOSITION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOLOGY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CASE-CONTROL STUDIES; COMORBIDITY; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEPROSY; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 44049090381     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490812300213     Document Type: Article

References (33)

1. Global leprosy situation. Wkly Epidemiol Rec 2000;82:225-232
2. Becx-Bleumink M, Berhe D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All-Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis 1992;60:173-184
3. Bwire R, Kawuma HJ. Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus. Trans R Soc Trop Med Hyg 1994;88:315-316 (Pubitemid 24206454)
4. Nery JA, Vieira LM, de Matos HJ, Gallo ME, Sarno EN. Reactional states in multibacillary Hansen disease patients during multidrug therapy. Rev Inst Med Trop Sao Paulo 1998;40:363-370 (Pubitemid 128472813)
5. Britton WJ, Lockwood DN. Leprosy reactions: current and future approaches to management. Baillière's Clin Infect Dis 1997;4:1-23. (Pubitemid 27414644)
6. World Health Organization/UNAIDS. A global view of HIV infection. 2007 [cited 2007 Sep 5]. Available from: URL: http://gamapserver.who.int/mapLibrary/ Files/Maps/HIVPrevalenceGlobal2006.png
7. World Health Organization. Leprosy today [cited 2007 Nov 26]. Available from: URL: http://www.who.int/lep/en
8. Shelburne SA, 3rd, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003;5:67-79.
9. Sampaio EP, Caneshi JRT, Nery JA, Duppre NC, Pereira GM, Vieira LM, et al. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun 1995;63:1848-1854
10. Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2003;36:e5-6.
11. Couppie P, Abel S, Voinchet H, Roussel M, Helenon R, Huerre M, et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004;140:997-1000. (Pubitemid 39062652)
12. SINAN. Sistema de Informações de Agravos de Notificação [cited 2007 Nov 12]. Available from: URL: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?hans/hanswuf.def
13. Ministério da Saúde. Boletim Epidemiológico AIDS/DST, ano III, no. 1. Brazil, 2007.
14. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-273
15. Jardim MR, Antunes SL, Wildenbeest JG, Nery JA, Illarramendi X, Moraes MO, et al. PGL-I as an accessory test for the diagnosis of pure neural leprosy. Lepr Rev 2005;76:232-240 (Pubitemid 43161272)
16. Guia de Vigilância Epidemiológica, 5th ed. Brasília: Fundação Nacional de Saúde; 2002.
17. Ministério da Saúde. Portaria No. 59. 2003 Jan 28. Edição No. 22. 2003 Jan 30. anexo II. Procedimentos seqüenciados para detecção de anticorpos anti-HIV em indivíduos com idade acima de dois anos.
18. SPSS Inc. SPSS for Windows: Version 11.0. Chicago: SPSS Inc.; 2003.
19. Mastroianni CM, Lichtner M, Mengoni F, D'Agostino C, Forcina G, d'Ettorre G, et al. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS 1999;13:883-890
20. Singal A, Mehta S, Pandhi D. Immune reconstitution inflammatory syndrome in an HIV seropositive leprosy patient. Lepr Rev 2006; 77:76-80.
21. Andrade VL, Moreira Alves T, Regazzi Avelleira JC, Bayona M. Prevalence of HIV-1 in leprosy patients in Rio de Janeiro, Brazil. Acta Leprol 1997;10:159-163 (Pubitemid 27317319)
22. Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis 2003;188:1794-1803 (Pubitemid 38064863)
23. Jacob M, George S, Pulimood S, Nathan N. Short-term follow-up of patients with multibacillary leprosy and HIV infection. Int J Lepr Other Mycobact Dis 1996;64:392-395 (Pubitemid 27057558)
24. Gebre S, Saunderson T, Messele T, Byass P. The effect of HIV status on the clinical picture of leprosy: a prospective study in Ethiopia. Lepr Rev 2000;71:338-343 (Pubitemid 30845918)
25. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006;6:350-360 (Pubitemid 43737271)
26. Borgdorff MW, van den Broek J, Chum HJ, Klokke AH, Graf P, Barongo LR, et al. HIV-1 infection as a risk factor for leprosy: a case-control study in Tanzania. Int J Lepr Other Mycobact Dis 1993;61:556-562 (Pubitemid 24129411)
27. Kawuma HJ, Bwire R, Adatu-Engwau F. Leprosy and infection with the human immunodeficiency virus in Uganda: a case-control study. Int J Lepr Other Mycobact Dis 1994;62:521-526
28. Lienhardt C, Kamate B, Jamet P, Tounkara A, Faye OC, Sow SO, et al. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali. Int J Lepr Other Mycobact Dis 1996;64:383-391 (Pubitemid 27057557)
29. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860
30. Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin Immunol 2002;102:154-161 (Pubitemid 34171514)
31. Krahenbuhl JL, Adams LB. Mycobacterium leprae as an opportunistic pathogen. In: Paradise LJ, editor. Opportunistic intracellular bacteria and immunity. New York: Plenum Press; 1999. p. 75-89.
32. Trindade MA, Manini MI, Masetti JH, Leite MA, Takahashi MD, Naafs B. Leprosy and HIV co-infection in five patients. Lepr Rev 2005;76:162-166 (Pubitemid 41039746)
33. Machado P, David Y, Pedroso C, Brutes C, Barral A, Barral-Netto M. Leprosy and HIV infection in Bahia, Brazil. Int J Lepr Other Mycobact Dis 1998;66:227-229